Effect of brown adipose tissue activation on myocardial fluorine-18-fluorodeoxyglucose uptake

Affiliations

14 January 2022

-

doi: 10.4103/wjnm.WJNM_16_19


Abstract

The aim of this study is to investigate the relationship between brown adipose tissue (BAT) activation and myocardial fluorine-18-fluorodeoxyglucose ([18F] FDG) uptake in terms of intensity and patterns. The patients were divided into two groups as follows: BAT and control groups. The BAT group consists of 34 cases that showed BAT uptake. The control group, with no BAT uptake, included 68 patients who were matched for body mass index, gender, and season. The scans were retrospectively reviewed by two nuclear medicine physicians who visually evaluated the intensity of myocardial [18F] FDG uptake. The myocardial [18F] FDG uptake was visually classified into the following three patterns: diffuse, heterogeneous, and focal. The regions of activated BAT distribution were noted. The mean myocardial [18F] FDG uptake was 2.50 ± 0.75 for the BAT group and 2.13 ± 0.88 for the control group with a statistically significant difference (P = 0.031). The myocardial [18F] FDG uptake pattern was similar in the BAT and control groups with the diffuse pattern being the most common, followed by the heterogeneous and less commonly focal. In the BAT group, the anatomical distribution of BAT was mainly in supraclavicular, paravertebral, and axillary and to a lesser extent in cervical regions. BAT group had a significantly higher intensity of [18F] FDG myocardial uptake compared to that of the control group. The presence of activated BAT did not affect the pattern of myocardial uptake. Knowledge of these findings may help in understanding the variability of myocardial [18F] FDG uptake and consequently in avoiding misinterpretation of cardiac findings in positron-emission tomography/computed tomography studies.

Keywords: Activated brown adipose fat; fluorine-18-fluorodeoxyglucose; myocardial uptake.


Figures


Similar articles

Active Brown Fat During 18F-FDG PET/CT Imaging Defines a Patient Group with Characteristic Traits and an Increased Probability of Brown Fat Redetection.

Gerngroß C, Schretter J, Klingenspor M, Schwaiger M, Fromme T.J Nucl Med. 2017 Jul;58(7):1104-1110. doi: 10.2967/jnumed.116.183988. Epub 2017 Jan 19.PMID: 28104743

FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.

Esen Akkas B, Gökaslan D, Güner L, Ilgin Karabacak N.Rev Esp Med Nucl. 2011 Jan-Feb;30(1):14-8. doi: 10.1016/j.remn.2010.05.006. Epub 2010 Aug 10.PMID: 20702004

Prevalence and pattern of brown adipose tissue distribution of 18F-FDG in patients undergoing PET-CT in a subtropical climatic zone.

Perkins AC, Mshelia DS, Symonds ME, Sathekge M.Nucl Med Commun. 2013 Feb;34(2):168-74. doi: 10.1097/MNM.0b013e32835bbbf0.PMID: 23196673

Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans.

Ouellet V, Routhier-Labadie A, Bellemare W, Lakhal-Chaieb L, Turcotte E, Carpentier AC, Richard D.J Clin Endocrinol Metab. 2011 Jan;96(1):192-9. doi: 10.1210/jc.2010-0989. Epub 2010 Oct 13.PMID: 20943785

Brown adipose tissue: distribution and influencing factors on FDG PET/CT scan.

Hao R, Yuan L, Zhang N, Li C, Yang J.J Pediatr Endocrinol Metab. 2012;25(3-4):233-7. doi: 10.1515/jpem-2012-0029.PMID: 22768649 Review.


KMEL References


References

  1.  
    1. Paidisetty S, Blodgett TM. Brown fat: Atypical locations and appearances encountered in PET/CT. AJR Am J Roentgenol. 2009;193:359–66. - PubMed
  2.  
    1. Liu X, Cervantes C, Liu F. Common and distinct regulation of human and mouse brown and beige adipose tissues: A promising therapeutic target for obesity. Protein Cell. 2017;8:446–54. - PMC - PubMed
  3.  
    1. Saito M. Brown adipose tissue as a regulator of energy expenditure and body fat in humans. Diabetes Metab J. 2013;37:22–9. - PMC - PubMed
  4.  
    1. Ouellet V, Routhier-Labadie A, Bellemare W, Lakhal-Chaieb L, Turcotte E, Carpentier AC, et al. Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. J Clin Endocrinol Metab. 2011;96:192–9. - PubMed
  5.  
    1. Himms-Hagen J. Brown adipose tissue thermogenesis: Interdisciplinary studies. FASEB J. 1990;4:2890–8. - PubMed
  6.  
    1. Hull D, Segall MM. Sympathetic nervous control of brown adipose tissue and heat production in the new-born rabbit. J Physiol. 1965;181:458–67. - PMC - PubMed
  7.  
    1. Takx RA, Ishai A, Truong QA, MacNabb MH, Scherrer-Crosbie M, Tawakol A. Supraclavicular brown adipose tissue 18F-FDG uptake and cardiovascular disease. J Nucl Med. 2016;57:1221–5. - PubMed
  8.  
    1. Saito M, Yoneshiro T. Capsinoids and related food ingredients activating brown fat thermogenesis and reducing body fat in humans. Curr Opin Lipidol. 2013;24:71–7. - PubMed
  9.  
    1. Sugita J, Yoneshiro T, Hatano T, Aita S, Ikemoto T, Uchiwa H, et al. Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in men. Br J Nutr. 2013;110:733–8. - PubMed
  10.  
    1. de Marchi SF, Schwerzmann M, Billinger M, Windecker S, Meier B, Seiler C, et al. Sympathetic stimulation using the cold pressor test increases coronary collateral flow. Swiss Med Wkly. 2001;131:351–6. - PubMed
  11.  
    1. Nose H, Otsuka H, Otomi Y, Terazawa K, Takao S, Iwamoto S, et al. The physiological uptake pattern of (18)F-FDG in the left ventricular myocardium of patients without heart disease. J Med Invest. 2014;61:53–8. - PubMed
  12.  
    1. Browne J, de Pierro AB. A row-action alternative to the EM algorithm for maximizing likelihood in emission tomography. IEEE Trans Med Imaging. 1996;15:687–99. - PubMed
  13.  
    1. Kaneta T, Hakamatsuka T, Takanami K, Yamada T, Takase K, Sato A, et al. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization. Ann Nucl Med. 2006;20:203–8. - PubMed
  14.  
    1. Abel ED. Glucose transport in the heart. Front Biosci. 2004;9:201–15. - PubMed
  15.  
    1. Maurer AH, Burshteyn M, Adler LP, Steiner RM. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT. Radiographics. 2011;31:1287–305. - PubMed
  16.  
    1. Hintsala H, Kenttä TV, Tulppo M, Kiviniemi A, Huikuri HV, Mäntysaari M, et al. Cardiac repolarization and autonomic regulation during short-term cold exposure in hypertensive men: An experimental study. PLoS One. 2014;9:e99973. - PMC - PubMed
  17.  
    1. Vosselman MJ, van der Lans AA, Brans B, Wierts R, van Baak MA, Schrauwen P, et al. Systemic β-adrenergic stimulation of thermogenesis is not accompanied by brown adipose tissue activity in humans. Diabetes. 2012;61:3106–13. - PMC - PubMed
  18.  
    1. Söderlund V, Larsson SA, Jacobsson H. Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol. Eur J Nucl Med Mol Imaging. 2007;34:1018–22. - PubMed
  19.  
    1. Lindholm H, Brolin F, Jonsson C, Jacobsson H. Effects on the FDG distribution by a high uptake of brown adipose tissue at PET examination. EJNMMI Res. 2014;4:72. - PMC - PubMed
  20.  
    1. Cronin CG, Prakash P, Daniels GH, Boland GW, Kalra MK, Halpern EF. Brown fat at PET/CT: Correlation with patient characteristics. Radiology. 2012;263:836–42. - PubMed
  21.  
    1. Jones TA, Reddy NL, Wayte SC, Adesanya O, Dimitriadis GK, Hutchinson CE, et al. Brown fat depots in adult humans remain static in their locations on PET/CT despite changes in seasonality. Physiol Rep. 2017;5 pii: e13284. - PMC - PubMed
  22.  
    1. Sacks H, Symonds ME. Anatomical locations of human brown adipose tissue: Functional relevance and implications in obesity and type 2 diabetes. Diabetes. 2013;62:1783–90. - PMC - PubMed
  23.  
    1. Basu S, Alavi A. Optimizing interventions for preventing uptake in the brown adipose tissue in FDG-PET. Eur J Nucl Med Mol Imaging. 2008;35:1421–3. - PubMed
  24.  
    1. Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl Med. 2007;48:1662–9. - PubMed
  25.  
    1. Thut DP, Ahmed R, Kane M, Djekidel M. Variability in myocardial metabolism on serial tumor (18)F-FDG PET/CT scans. Am J Nucl Med Mol Imaging. 2014;4:346–53. - PMC - PubMed
  26.  
    1. Tiwari BP, Kand P. Myocardial uptake of F-18-fluorodeoxyglucose in whole body positron emission tomography studies. Indian J Nucl Med. 2012;27:69–72. - PMC - PubMed
  27.  
    1. Fallahi B, Moasses-Ghafari B, Fard-Esfahani A, Geramifar P, Beiki D, Emami-Ardekani A. Myocardial18 F-FDG uptake in oncologic PET-CT imaging. Iran J Nucl Med. 2017;25:52–61.